Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-28

Clinical Trial Update: Ketorolac for Moderate to Severe Abdominal Pain in Children [Phase 3]

View source ↗

Summary

Phase 3 trial assessing ketorolac for moderate to severe abdominal pain in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Abdominal Pain, Appendicitis | Phase 3 | Status: COMPLETED